Endoalveolar haemorrhage due to methotrexate overdosage in a patient treated for psoriatic arthritis

Journal of Dermatological Treatment

Volumn 10, Issue 1, 1999, Pages 67-69

  Kokelj, F ^a,b,c   Plozzer, C ^a,b   Muzzi, A ^a,b   Ciani, F ^a,b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Physiopathology Respiratory Service   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Adverse reaction; Endoalveolar haemorrhage; Methotrexate; Psoriasis

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COUGHING; DRUG OVERDOSE; DYSPNEA; FEMALE; FEVER; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LUNG ALVEOLUS; LUNG HEMORRHAGE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS;

EID: 0032987029     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639909055914     Document Type: Article

References (5)

1. Green L, Schattner A, Berkenstadt H, Severe reversible interstitial pneumonitis induced by low dose methotrexate: report of a case and review of the literature. J Rhewnatol (1988) 15:110-12.
2. From E, Methotrexate pneumonitis in a psoriatic. Br J Denimfol(1975)93: 107-9.
3. Filip DJ, Logue GL, Harle TS, Farrar WH, Pulmonary and hepatic complications of methotrcxate therapy of psoriasis. JAMA (1971) 216: 881-2.
4. Akoun GM, Mayaud CM, Touboul JL et al. Use of bronchoalveolar lavage in the evaluation of methotrexate lung disease. Thorax (1987) 42: 652-5.
5. Cooper JAD, White DA, Matthay RA, Drug induced pulmonary disease: part 1. Am Rev Respir Dis (1986) 133: 321-40.